The Rise of Portable Fluoroscopy Devices is Estimated to Witness High Growth Owing to Opportunity for Real Time Imaging
Fluoroscopy devices are X-ray imaging devices that capture real-time moving images for medical examination and medical procedures. These devices are used in various clinical procedures such as orthopedics, urology, gastroenterology, cardiology, and pain management. Advantages of fluoroscopy include real-time imaging capability, affordability compared to CT and MRI devices, and portability for bedside imaging. The increasing demand for minimally invasive procedures along with growing geriatric population has fueled the need for fluoroscopy devices.
The global fluoroscopy devices market is estimated to be valued at US$ 4720.31 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
The opportunity for real time imaging is estimated to witness high growth in the fluoroscopy devices market size. Portable fluoroscopy devices allow physicians to perform imaging at patient's bedside which provides real time visualization during various procedures. This has huge benefits over traditional c-arm devices as it ensures improved patient comfort, reduced procedure time, and mobility within limited spaces. The rising demand for point-of-care diagnosis and treatment has boosted the demand for portable fluoroscopy devices in recent years. With continued technological advancements, portable fluoroscopy devices are finding increased adoption in ambulatory surgical centers and specialty clinics as well. The market opportunity around real time imaging capabilities of portable fluoroscopy devices is projected to propel the overall industry growth during the forecast period.
Porter’s Analysis
Threat of new entrants: Low capital requirements for manufacturing basic fluoroscopy devices limits the threat of new entrants. However, established brands and need for extensive research and regulatory approvals for new innovative products create high entry barriers.
Bargaining power of buyers: Individual buyers have low bargaining power due to undifferentiated products but larger hospitals and diagnostic chains can negotiate on price and demand additional services due to higher purchase volumes.
Bargaining power of suppliers: A few large multinational corporations dominate the production of core device components like tubes and image intensifiers creating higher supplier bargaining power.
Threat of new substitutes: Technologies like CT and MRI pose a substitute threat but are more expensive. Portable ultrasound devices are growing substitutes for select fluoroscopy applications.
Competitive rivalry: The market is consolidated with top players competing on product features, pricing and expanding into emerging markets.
SWOT Analysis
Strengths: Non-invasive real time imaging, portable devices aid point of care applications, growing demand due to aging population and disease incidence
Weaknesses: High device cost, radiation safety concerns, lack of skilled professionals in developing nations
Opportunities: Rising healthcare spending in emerging nations, miniaturization and technological advances and expanding diagnostic applications
Threats: Stringent regulations, reimbursement policies, substitute technologies
Key Takeaways
The global Fluoroscopy Devices Market is expected to witness high growth at a CAGR of 4.2% during the forecast period of 2023 to 2030. The market size for 2023 is US$ 4720.31 million.
Regional analysis indicates North America will continue dominating the market due to rapidly expanding diagnostic imaging capacities and availability of advanced devices. Asia Pacific is anticipated to grow at the fastest rate led by China and India with increasing healthcare investments and rising focus on quality care.
Key players operating in the Fluoroscopy Devices market are Bayer AG, Henkel AG & Co. KgaA, Avon Products Inc., Johnson & Johnson Inc., Kao Corporation, Beiersdorf AG, Groupe Clarins SA, Revlon Inc., Shiseido Co. Ltd., Unilever PLC, Procter & Gamble, Lotus Herbals Pvt. Ltd. The companies are focused on new product launches, capacity expansion in high growth regions and mergers & acquisitions to strengthen their market position.
Get more insights on this topic:
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian